Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on March 28, 2026

Mar. 28, 2026

Malatya Apricot | Dates, Prunes, Almonds Drive Global Demand for Sustainable Snacking Solutions - Health

Indeterminate EIN Presswire

Mar. 28, 2026

Mandara Spa at Cinnamon Hakuraa Huraa Maldives recognised at Luxuri Awards 2026

Indeterminate EIN Presswire

Mar. 28, 2026

MGTT to Showcase High-Volume Manufacturing Excellence in Sleep & Wellness hardware for Baby and Toddler at ABC Kids Expo

Indeterminate EIN Presswire

Mar. 28, 2026

Keep It Blue Pool Service Introduces Green to Clean Restoration for Spring Hill, FL Pool Owners

Indeterminate EIN Presswire

Mar. 28, 2026

C&S Contracting Expands Walk-In Tub Services for Seniors Across Pasco County, Florida

Indeterminate EIN Presswire

Mar. 28, 2026

Sports Cards Reserve reports 400% jump in Cooper Flagg card transactions as NBA playoff race heats up

Indeterminate EIN Presswire

Mar. 28, 2026

Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)

Indeterminate GlobeNewswire

Mar. 28, 2026

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

Indeterminate GlobeNewswire

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

Indeterminate GlobeNewswire

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Indeterminate GlobeNewswire

Mar. 28, 2026

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

Indeterminate GlobeNewswire

Mar. 28, 2026

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Indeterminate GlobeNewswire

Mar. 28, 2026

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

Indeterminate GlobeNewswire

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

Indeterminate GlobeNewswire

Mar. 28, 2026

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Indeterminate GlobeNewswire

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Indeterminate GlobeNewswire

Mar. 28, 2026

TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026

Indeterminate GlobeNewswire

Mar. 28, 2026

THE CHAMPIONS COLLECTIVE PRESENTS THE DODGERS’ 2025 WORLD SERIES RING FEATURING GAME SEVEN DIRT

Indeterminate GlobeNewswire